Tagra Biotechnologies, since its inception in 1998, focuses on developing and manufacturing microencapsulated ingredients such as actives, pigments, essential oils, UV filters, and highly water-soluble ingredients. Tagra is the first to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other cosmetic and pharmaceutical formulation ingredients. The technology enables the masking, protecting, and releasing of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer applications. Tagra also owns and operates its own plant and state-of-the-art laboratory meeting all required regulations.